NOAEL Studies
Cosmetic Ingredient
HC Red No. 10 NOAEL Studies
INCI: HC RED NO. 10
CAS: Verify against current CosIng - chemical names listed include 1-Amino-2-nitro-4-(2',3'-dihydroxypropyl)amino-5-chlorobenzene and 1,4-Bis-(2',3'-dihydroxypropyl)amino-2-nitro-5-chlorobenzene
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
SCCS Opinion 12 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =40 | mg/kg bw | rat | oral | 90-day | irritation | p.5 |
| SCCS Opinion | NOAEL | =0.0022 | mg/kg bw | rat | dermal | 90-day | dermal absorption | p.5 |
| SCCS Opinion | NOAEL | =20 | mg/kg bw/d | rat | - | 6 weeks | NOAEL study | p.23 |
| SCCS Opinion | NOAEL | =100 | mg/kg bw/d | human | - | - | NOAEL study | p.29 |
| SCCS Opinion | NOAEL | =0.7 | mg/kg bw/d | - | oral | subchronic | repeated dose toxicity | p.30 |
| SCCS Opinion | NOAEL | =0.006 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.31 |
| SCCS Opinion | NOAEL | =10.4 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.31 |
| SCCS Opinion | NOAEL | =0.004 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.31 |
| SCCS Opinion | NOAEL | =0.0008 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.31 |
| SCCS Opinion | NOAEL | =7.1 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.31 |
| SCCS Opinion | NOAEL | =0.0006 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.32 |
| SCCS Opinion | NOAEL | =35.4 | % | - | oral | subchronic | repeated dose toxicity | p.33 |
Regulatory source 16 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 20 | mg/kg bw/d | rat | - | 6 weeks | - | p.23 |
| Regulatory source | - | 20 | mg/kg bw/d | - | - | 6 weeks | - | p.23 |
| Regulatory source | - | 100 | mg/kg bw/d | human | - | - | - | p.29 |
| Regulatory source | dermal absorption | 0.0022 | mg/kg bw | rat | dermal | 90-day | dermal absorption | p.5 |
| Regulatory source | dermal absorption | =0.006 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.31 |
| Regulatory source | dermal absorption | =10.4 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.31 |
| Regulatory source | dermal absorption | =0.004 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.31 |
| Regulatory source | dermal absorption | =0.0008 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.31 |
| Regulatory source | dermal absorption | =7.1 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.31 |
| Regulatory source | dermal absorption | =0.0006 | mg/kg bw/d | rat | oral | 90 d | dermal absorption | p.32 |
| Regulatory source | irritation | 40 | mg/kg bw | rat | oral | 90-day | irritation | p.5 |
| Regulatory source | repeated dose toxicity | 20 | mg/kg bw/d | human | oral | subchronic | repeated dose toxicity | p.30 |
| Regulatory source | repeated dose toxicity | 0.7 | mg/kg bw/d | - | oral | subchronic | repeated dose toxicity | p.30 |
| Regulatory source | repeated dose toxicity | 20 | mg/kg bw/d | rat | oral | sub-chronic | repeated dose toxicity | p.33 |
| Regulatory source | repeated dose toxicity | 100 | mg/kg bw/d | rat | oral | sub-chronic | repeated dose toxicity | p.33 |
| Regulatory source | repeated dose toxicity | 35.4 | % | - | oral | subchronic | repeated dose toxicity | p.33 |